Mots-C

Overview

MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome, specifically the 12S ribosomal RNA gene. Most peptides come from nuclear DNA. MOTS-c doesn't. That makes it a member of a relatively new class called mitochondrial-derived peptides (MDPs), a category that didn't really exist in the literature until Changhan David Lee's group at the University of Southern California described it in 2015.

The mitochondrial origin isn't just a fun fact. It's central to why researchers find this compound interesting. MOTS-c appears to function as a retrograde signal, carrying information from mitochondria back to the nucleus and influencing gene expression in ways that link metabolic state to cellular stress responses. That's an unusual signaling axis for a peptide of this size.

Published research on MOTS-c covers AMPK activation, folate cycle modulation, and nuclear translocation behavior. The research base is newer compared to more established peptides, but it's growing quickly, with publications across metabolomics, aging biology, and exercise physiology.

Biochemical Characteristics

MOTS-c has a 16-residue sequence (MRWQEMGYIFYPRKLR) with a molecular formula of C₇₈H₁₂₁N₂₁O₂₃S₂ and a molecular weight of approximately 1765 g/mol. It's a small peptide by typical standards, compact enough to translocate across membranes, which is part of what makes the nuclear localization data in published studies notable.

The peptide contains methionine and tryptophan residues that contribute to its biochemical behavior. It's classified as an endogenous peptide, meaning it's produced naturally within cells rather than being a synthetic analog of another compound. The sequence is conserved across mammals, which has informed comparative studies in rodent models.

WhyNot Labs' batch WNL-2602-K01 is supplied as lyophilized powder, ≥98% purity, independently verified by Vanguard Laboratory under a 7-panel conformity protocol. Store at -20°C and protect from light.

Research Applications

Published research involving MOTS-c has examined several areas. AMPK pathway activation studies represent the largest body of in vitro work, with cell-based assays exploring how MOTS-c influences downstream signaling in metabolic contexts. The folate cycle and de novo purine biosynthesis pathway, specifically AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) accumulation, has also been examined in published metabolomics work.

Aging biology has been another active area, with several papers examining MOTS-c in the context of mitochondrial peptide signaling and age-related changes in metabolic function. Exercise physiology researchers have looked at endogenous MOTS-c levels in response to physical activity in preclinical models, though this work remains at the investigation stage.

The nuclear translocation research is its own thread. Published cell culture studies have shown MOTS-c localizing to the nucleus under stress conditions and influencing nuclear gene expression. This bidirectional, mitochondria-to-nucleus signaling behavior is not common for peptides of this class, and it's drawn interest from researchers studying the broader MDP field.

Pathway & Mechanistic Context

AMPK (AMP-activated protein kinase) sits at a key node in cellular energy sensing. When energy availability drops and the AMP:ATP ratio rises, AMPK activates and triggers a coordinated response that includes shifts in glucose and fatty acid metabolism, inhibition of anabolic pathways, and autophagy induction. Published research has shown that MOTS-c can activate AMPK in cell culture systems, placing the compound upstream of these downstream effects.

The folate cycle connection is tied to AICAR. MOTS-c has been shown in metabolomics studies to influence the folate cycle, leading to AICAR accumulation. AICAR is itself an AMPK activator, which may represent one mechanism by which MOTS-c influences the pathway, though the full picture is still being characterized in the literature.

The nuclear translocation piece adds another layer. MOTS-c's ability to move from the cytoplasm into the nucleus under cellular stress, and its subsequent influence on nuclear gene transcription patterns, suggests a more direct regulatory role than simple ligand-receptor signaling. Research in this area is ongoing.

Preclinical Research Summary

The foundational 2015 Cell Metabolism paper by Lee et al. identified MOTS-c as a mitochondrial-derived peptide and described its effects on glucose metabolism and insulin sensitivity in cell culture and rodent models. That paper established the AMPK connection and the folate cycle mechanism, and it's been cited extensively in subsequent work.

Subsequent rodent studies have examined MOTS-c in contexts including diet-induced metabolic disruption, aging-associated changes, and physical conditioning. These are animal and cell-culture studies, not human clinical trials, and the findings can't be extrapolated to human outcomes.

Research on the relationship between exercise and circulating MOTS-c levels has appeared in several publications, examining whether physical activity modulates endogenous peptide levels. This work is early-stage and observational in nature. No human therapeutic use has been established or approved.

Form & Analytical Testing

Batch WNL-2602-K01 is supplied as lyophilized (freeze-dried) powder, 40mg per vial, sealed under inert atmosphere. Lyophilization removes water while preserving peptide integrity, extending shelf stability compared to solution form when stored correctly.

Every WhyNot Labs batch goes through 7-panel conformity testing at Vanguard Laboratory (ISO/IEC 17025:2017 accredited, A2LA certified). The protocol covers identity confirmation, purity analysis, net content verification, endotoxin screening, heavy metals testing, sterility testing, and conformity documentation. Five vials per batch are submitted, not a single sample, which is a more rigorous approach than single-vial testing.

The Certificate of Analysis for batch WNL-2602-K01 will be published to the COA Library once testing is complete. Expected turnaround is 17 to 21 days from submission. The COA page is linked via QR code on every vial label.

Referenced Citations

Lee C, et al. MOTS-c: A mitochondrial-derived peptide regulating muscle and fat metabolism. Cell Metab. 2015;21(3):443-454. PMID: 25738459.

Kim SJ, et al. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595(21):6613-6621. PMID: 28762527.

Yin X, et al. The circulating mitochondrial peptide MOTS-c positively correlates with metabolic parameters in elderly subjects. Aging. 2021;13(2):1948-1966. PMID: 33411680.

Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PMID: 33469022.